BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Sandoz Announces New Phase I Data Showing Proposed Biosimilar Pegfilgrastim Matches Reference Medicine

  The Phase I study, conducted in healthy volunteers, confirmed that Sandoz biosimilar pegfilgrastim matches the reference biologic in terms of PK, PD, safety and immunogenicity profiles.

  December 8, 2017

   · 

  6 min read
• ANGLE plc Announces Parsortix Potential in Metastatic Breast Cancer

  ANGLE plc is delighted to announce that the University of Southern California (USC) Norris Comprehensive Cancer Center yesterday presented results of extensive work with ANGLE’s Parsortix system at the San Antonio Breast Cancer Symposium (SABCS).

  December 8, 2017

   · 

  8 min read
• Drug Development

  ARMO BioSciences Presents Efficacy Data From its Phase Ib Trial in Patients With Metastatic Renal Cell Carcinoma at ESMO Immuno-Oncology Congress 2017

  ARMO BioSciences today announced additional clinical trial results on its lead investigational immuno-oncology drug AM0010 in metastatic renal cell carcinoma.

  December 8, 2017

   · 

  4 min read
• 

  Business

  HighLife Names Former Biosensors CEO as Chairman of the Board

  Pepe brings 30 years of experience in the medical device industry, having served in various executive and managerial roles at Biosensors, Abbott, Guidant and Eli Lilly.

  December 8, 2017

   · 

  3 min read
• Biotech Beach

  Genervon’s GM604 Is a Multi-Target Regulator That Provides a Novel Treatment Strategy for ALS

  Genervon is presenting its recent findings at the 28th national symposium on ALS/MND in Boston on Saturday, December 9, 2017.

  December 8, 2017

   · 

  2 min read
• Business

  Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders

  Together, Synlogic and Ginkgo aim to transform the discovery and design of living medicines.

  December 8, 2017

   · 

  6 min read
• Pharm Country

  Impax Receives Tentative FDA Approval of Generic Coreg CR (Carvedilol Phosphate) Extended-Release Capsules

  The Company’s ANDA is eligible for final approval upon the expiration of marketing exclusivity on May 7, 2018.

  December 8, 2017

   · 

  5 min read
• Drug Development

  Arvinas Presents New Data on Oral Estrogen Receptor PROTAC Degrader at 2017 San Antonio Breast Cancer Symposium

  Arvinas today announced the presentation of new preclinical data for its novel oral estrogen receptor alpha PROTAC program during a poster session at the 2017 SABCS.

  December 8, 2017

   · 

  2 min read
• Drug Development

  Encouraging Updated Results From Phase Ib/II Study Evaluating the Combination of Eribulin Mesylate and Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer Presented at the 2017 SABCS

  Findings presented during the 2017 SABCS showed the combination of eribulin and pembrolizumab resulted in an objective response rate of 26.4% the primary efficacy endpoint of the study.

  December 8, 2017

   · 

  10 min read
• SGS Launches New Large Molecule Bioanalytical Services

  SGS is now offering clients large molecule bioanalytical services at its laboratory in Wavre, Belgium.

  December 8, 2017

   · 

  2 min read